Summary
Saniona AB (Saniona) is a research and development (R&D) company that discovers and develops drugs for the treatment of diseases related to central nervous system, autoimmune diseases and pain. It offers a product pipeline in the therapeutic areas of schizophrenia and Alzheimer’s disease, major depressive disorder, neuropathic pain, inflammation and schizophrenia, among others. The company also offers a a monoamine uptake inhibitor, Tesofensine, which focuses on Obesity And Type 2 Diabetes. Saniona conducts research on three classes of ion channels including GABAA receptors, nicotinic acetylcholine receptors and potassium channels. It works in partnership with Pfizer and Ataxion. Saniona is headquartered in Copenhagen, Denmark.
Saniona AB (SANION) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Saniona AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Saniona AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Saniona AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Saniona AB, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Saniona Acquires Rights of Tesofensine from NeuroSearch 10
Aniona Acquires Portfolio of Preclinical Assets from NeuroSearch 11
Partnerships 12
Proximagen Enters into Co-Development Agreement with Saniona 12
Saniona Enters into Agreement with Syngene 13
Saniona Extends R&D Agreement with Ataxion 14
Saniona Extends R&D Agreement with Janssen Pharmaceutica 15
Licensing Agreements 16
Pfizer Terminates Licensing Agreement with Saniona 16
Equity Offering 17
Saniona Completes IPO For US$2.6 Million 17
Asset Transactions 18
Ataxion Acquires Ataxia Program from Saniona 18
Saniona AB - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Saniona AB, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Saniona AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Saniona AB, Deals By Therapy Area, 2010 to YTD 2016 8
Saniona AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Saniona Acquires Rights of Tesofensine from NeuroSearch 10
Aniona Acquires Portfolio of Preclinical Assets from NeuroSearch 11
Proximagen Enters into Co-Development Agreement with Saniona 12
Saniona Enters into Agreement with Syngene 13
Saniona Extends R&D Agreement with Ataxion 14
Saniona Extends R&D Agreement with Janssen Pharmaceutica 15
Pfizer Terminates Licensing Agreement with Saniona 16
Saniona Completes IPO For US$2.6 Million 17
Ataxion Acquires Ataxia Program from Saniona 18
Saniona AB, Key Competitors 19
Saniona AB, Key Employees 20
List of Figures
Saniona AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Saniona AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Saniona AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Saniona AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Saniona AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Saniona AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8